A
Adrian C Bateman
Researcher at University Hospital Southampton NHS Foundation Trust
Publications - 146
Citations - 8121
Adrian C Bateman is an academic researcher from University Hospital Southampton NHS Foundation Trust. The author has contributed to research in topics: Cancer & Neoadjuvant therapy. The author has an hindex of 42, co-authored 142 publications receiving 7188 citations. Previous affiliations of Adrian C Bateman include Royal Hampshire County Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
TL;DR: The results indicate that, whereas Ki-67 immunohistochemistry predicts survival in patients with astrocytic tumours, conventional histological appraisal remains the best guide to prognosis, and immunohistsochemistry for p53 has no value in the assessment of these tumours.
Journal ArticleDOI
Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease.
Toshiki Mimura,Adrian C Bateman,Ron Lee,Penelope A. Johnson,Peter J. McDonald,Ian C. Talbot,Michael A. Kamm,Thomas T. MacDonald,Sylvia L.F. Pender +8 more
TL;DR: Colonic diverticulosis is associated with altered collagen content and tissue inhibitor of metalloproteinases expression, which may play a role in remodeling the gut wall in this condition.
Journal ArticleDOI
EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
TL;DR: In the study group, the EGF +61 polymorphism was not a risk factor for CMM susceptibility, but this polymorphism may play a role in disease progression.
Journal ArticleDOI
Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance
Charles N. Birts,Rachael Harding,Gehan Soosaipillai,Trisha Halder,Ali Azim-Araghi,Matthew Darley,Ramsey I. Cutress,Adrian C Bateman,Jeremy P. Blaydes +8 more
TL;DR: Little is known of the expression or regulation of CtBP isoforms in human cancer, nor of the relative contributions of CTBP1 and CTBP2 to the tumour cell phenotype.
Journal ArticleDOI
Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
Mohammad Shahid,Aysha Mubeen,Julie Y. Tse,Sanjay Kakar,Adrian C Bateman,Darrell R. Borger,Miguel Rivera,David T. Ting,Vikram Deshpande +8 more
TL;DR: Branched chain ISH performed on manual and automated mode is a robust assay for detecting albumin with sensitivity for poorly differentiated HCCs superior to Arginase-1 and Hep Par 1.